Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
Date:10/30/2008

liation of non-GAAP measures to their most closely applicable GAAP measure set forth below and should consider non-GAAP measures only as a supplement to, not as a substitute for or as a superior measure to, measures of financial performance prepared in accordance with GAAP.

Below is a reconciliation of adjusted net earnings and adjusted diluted EPS to GAAP net earnings (loss) and diluted GAAP EPS for the three and nine months ended Sept. 30, 2008:

(in millions except per share Three months ended Nine months ended

amounts) September 30, 2008 September 30, 2008

GAAP net earnings (loss) & diluted

GAAP EPS (1) $206.8 $0.45 $(280.3) $(0.92)

Purchase accounting related

amortization (2) 105.4 335.7

Goodwill impairment charge - 385.0

Bystolic revenue (455.0) (468.1)

Non-cash interest expense 1.0 1.0

Integration and other non-recurring

expenses (3) 26.8 91.3

Tax effect of the above items (4) 220.4 95.0

Adjusted net earnings and adjusted

diluted EPS $105.4 $0.23 $159.6 $0.52

Weighted average diluted common

shares (1) 458.4 304.3

(1) For the calculation of diluted EPS for the nine months, the GAAP net

loss includes the preferred dividend and does not assume conversion of

the preferred stock into common shares as to do so would be anti-

dilutive. However, for the three months, the conversion of these

shares is assumed in the weighted average diluted common shares, and

as such, the preferred dividend is excluded from GAAP net earnings in

the calculation of diluted EPS.

(2) I
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
2. Mylan to Host Investor Day on October 3, 2007
3. Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
4. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
5. Mylan Announces Tentative FDA Approval for Lamotrigine Tablets
6. Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
7. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
8. Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
9. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
10. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015  Steep Hill, the industry leader ... internationally, intends to open a full service medical cannabis ... , bringing advanced scientific tools and methodology to ... Steep Hill is currently the only laboratory licensed by ... and contaminant testing in order to meet the recently ...
(Date:2/26/2015)... N.J. , Feb. 26, 2015 On ... and its affiliated companies, Wilentz, Goldman & Spitzer, ... trade secrets lawsuit against Genewiz Inc. in excess of ... and utilized GenScript,s trade secrets, and that it improperly ... entered an order denying motions for judgment notwithstanding the ...
(Date:2/26/2015)... LEXINGTON, Mass., Feb. 26, 2015   Synageva ... a biopharmaceutical company developing therapeutic products for rare ... and provided 2015 goals, other key objectives, and ... conference call today at 4:30 p.m. EST to ... business update.  To participate in today,s call by ...
(Date:2/26/2015)... , Feb. 26, 2015 DuPont Executive Vice ... driven by key research advancements and product launches across ... Bank of America Merrill Lynch 2015 Global Agriculture Conference. ... of building grain supplies the last two years, long-term ... the pace of the last decade, when demand for ...
Breaking Biology Technology:Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
... Icahn confirmed today that,entities affiliated with him have given ... persons at Biogen,s forthcoming 2008 Annual,Meeting of Stockholders to ... board of twelve directors, and there are four directorships,up ... "We are taking this action because we believe,that Biogen,s ...
... The VenaFlux(TM) Platform Accurately Mimics a Human ... Cellix Ltd., an international,provider of microfluidic systems ... its worldwide launch of its VenaFlux(TM),Platform. The ... based assay system, measures cell adhesion to,antibody-coated ...
... Alexion,Pharmaceuticals, Inc. (Nasdaq: ALXN ), today announced that ... cast on Thursday, February 14,2008, at 10:00 a.m. Eastern ... results for the fourth quarter and full year ended ... 6:30 a.m.,ET on Thursday, February 14, 2008., To ...
Cached Biology Technology:Icahn Confirms Intention to Nominate Three Directors at Biogen 2Icahn Confirms Intention to Nominate Three Directors at Biogen 3Cellix Ltd. Launches the First Semi-Automated, High Throughput Cell-Adhesion Assay Platform 2
(Date:2/23/2015)... 23, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD ... a new groundbreaking payment method. Payment accounts may be ... only be accessed if both the speech (the word ...
(Date:2/12/2015)... OXFORD, Conn. , Feb. 12, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... it has filed provisional patent 62/113114 for ... MULTIPLE DEVICES. The patent further establishes NXT-ID,s ... to its intellectual property portfolio the ability for multiple ...
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken Launches New Patient-Centric Campaign 2
... Columbine flowers are recognizable by the long, trailing nectar ... tempting the taste buds of their insect pollinators. ... Santa Barbara (UCSB) helps to explain how columbines have ... flowers apparently tailored to the length of their pollinators, ...
... partnership with the Office of Naval Research (ONR), Marines ... disposal system that can reduce a standard 50-gallon bag ... Called the Micro Auto Gasification System (MAGS), the ... Forces, Pacific (MARFORPAC) as a possible solution to help ...
... today demonstrates the brain,s remarkable capacity to repair itself. ... limit damage after blood and oxygen deprivation and blood ... Neuroscience,s annual meeting and the world,s largest source of ... is the number one cause of long-term disability and ...
Cached Biology News:Dramatic diversity of columbine flowers explained by a simple change in cell shape 2Dramatic diversity of columbine flowers explained by a simple change in cell shape 3Marines test new energy-efficient weapon in the war on trash 2Brain, repair thyself: Studies highlight brain's resiliency to damage 2
Human SCP3 Affinity Purified Polyclonal Ab Keywords: Spermatogenesis, meiosis Protein Family: Cell Cycle...
... NAP-10 Columns, 50. For rapid and ... 10-mers) in less than 15 minutes by ... in distilled water containing 0.15% Kathon CG/ICP ... volume: 0.5 ml (NAP-5), 1 ml ...
Homo sapiens alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5), mRNA....
Human Serpin A3 MAb (Clone 213907)...
Biology Products: